This editorial discusses primary prophylaxis of venous thromboembolism and the role of biomarkers in ambulatory patients with active cancer.
This editorial refers to ‘Venous thromboembolism and bleeding in cancer patients: role of inflammatory and cardiac biomarkers’, by D.C. Roy et al., https:/
FARMAKIS et al. (Mon,) studied this question.